Clinical Trials
3 trialsNCT05470283 2026-04-16
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03467360 2026-01-20
ICAR
Centre Antoine Lacassagne
Phase 1 Recruiting
NCT04470843 2022-09-23
Impact of Acetazolamide in Reducing Referred Postoperative Pain
Medical College of Wisconsin
Phase 1 Completed